Family Medicine Doctors in Davison, MI Accepting Medicare

8 Family Medicine doctors found. Showing 1 - 8

Dr. Christie L Samuels, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8020 Davison Rd, Davison, MI 48423 Phone: 810-653-4145    Fax: 810-653-1741

English Autumn Karas, PA Family Medicine Medicare: Medicare Enrolled Practice Location: 9171 Lapeer Rd Ste 100, Davison, MI 48423 Phone: 810-412-5590

Dr. Thomas L Bossi, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8020 Davison Rd, Davison, MI 48423 Phone: 810-653-4145    Fax: 810-653-1741

Dr. Stanley J Conhon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10090 E Lippincott Blvd, Davison, MI 48423 Phone: 810-658-1130    Fax: 810-658-8589

Angela Marie Schultz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3390 N State Rd, Davison, MI 48423 Phone: 810-653-9282    Fax: 810-658-0001

Jennifer L Klock, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1510 S State Rd, Ste D, Davison, MI 48423 Phone: 810-652-3600    Fax: 810-652-3603

Dr. Alan P Weamer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8020 Davison Rd, Davison, MI 48423 Phone: 810-653-4145    Fax: 810-653-1741

Dr. Brian J Beck, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 10090 E Lippincott Blvd, Davison, MI 48423 Phone: 810-653-1130    Fax: 810-658-0589

News Archive

Merck's MK-4305 improves overall sleep efficiency in primary insomnia patients

Clinical results from a Phase IIb study showed that MK-4305, Merck's investigational dual orexin receptor antagonist, was significantly more effective than placebo (p<0.005) in improving overall sleep efficiency at night one and at the end of week four in patients with primary insomnia. MK-4305 was generally well-tolerated in the study. Orexins are neuropeptides (chemical messengers) that are released by specialized neurons in the hypothalamus region of the brain and are believed to be an important regulator of the brain's sleep-wake process.

Study examines the side effects of Alzheimer's disease dementia drugs

In a first of its kind study, a University of Houston researcher is examining two common drugs used for dementia in patients with Alzheimer's disease to determine the extent to which they don't mix well together and cause a cascading event of side effects, prompting the need for even more medications.

IDFA applauds U.S Senate Committee for child nutrition legislation

The International Dairy Foods Association applauded the leadership of Chairman Blanche Lincoln (D-AR), U.S. Senate Committee on Agriculture, Nutrition and Forestry, on the passage of child nutrition legislation that strengthens federal feeding programs. The federal child nutrition programs include the National School Lunch Program, School Breakfast Program, Special Supplemental Program for Women Infants, and Children (WIC) and the Child and Adult Care Food Program.

New FDA-approved heart pump for high-risk patients

Cardiologists at the University of Illinois Medical Center are using a new heart pump that can be inserted without the need for surgery and allows them to treat high-risk patients with a procedure to unblock their heart arteries.

Rutgers scientist receives $2.4 million grant to reduce indoor tanning among young women

A five-year, $2.4 million grant from the National Cancer Institute awarded to Rutgers Cancer Institute of New Jersey behavioral scientist Jerod L. Stapleton, PhD, will support the development and testing of a novel behavioral intervention delivered through the social media site Facebook to reduce high-risk indoor tanning behaviors among young women.

Read more Medical News

› Verified 7 days ago